{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:49:02Z","timestamp":1768736942232,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.numecd.2008.07.004","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T16:17:05Z","timestamp":1221754625000},"page":"574-579","source":"Crossref","is-referenced-by-count":40,"title":["Role of the incretin system in the remission of type 2 diabetes following bariatric surgery"],"prefix":"10.1016","volume":"18","author":[{"given":"G.","family":"Mingrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2008.07.004_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-2004-826154","article-title":"A centenary of gastrointestinal endocrinology","volume":"36","author":"Rehfeld","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.numecd.2008.07.004_bib2","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1172\/JCI105685","article-title":"Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects","volume":"46","author":"Perley","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2008.07.004_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","article-title":"The incretin concept today","volume":"16","author":"Creutzfeldt","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2008.07.004_bib4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diabetes.24.12.1050","article-title":"Gastric inhibitory polypeptide: its physiologic release and insulinotropic action in the dog","volume":"24","author":"Pederson","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(02)00039-3","article-title":"Gastric inhibitory polypeptide: the neglected incretin revisited","volume":"107","author":"Meier","year":"2002","journal-title":"Regul Pept"},{"key":"10.1016\/j.numecd.2008.07.004_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.1992.tb01464.x","article-title":"Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man","volume":"22","author":"Eissele","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.numecd.2008.07.004_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/edrv-16-3-390","article-title":"Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide","volume":"16","author":"Fehmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2008.07.004_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00125-002-1028-x","article-title":"Effects of the novel (Pro(3))GIP antagonist and exendin(9\u201339)amide on GIP and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob\/ob) mice: evidence that GIP is the major physiological incretin","volume":"46","author":"Gault","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2008.07.004_bib9","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/en.137.6.2383","article-title":"Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut","volume":"137","author":"Roberge","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2008.07.004_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diabetes.48.5.1026","article-title":"Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob\/ob, db\/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)","volume":"48","author":"Young","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel group study","volume":"359","author":"Zander","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2008.07.004_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0024-3205(99)00314-8","article-title":"GIP biology and fat metabolism","volume":"66","author":"Yip","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.numecd.2008.07.004_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2008.07.004_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/me.2002-0306","article-title":"Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis","volume":"17","author":"Drucker","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.numecd.2008.07.004_bib15","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1210\/en.2003-1147","article-title":"Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis","volume":"144","author":"Drucker","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2008.07.004_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.0.1010249","article-title":"Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob\/ob) mice","volume":"101","author":"Flatt","year":"1984","journal-title":"J Endocrinol"},{"key":"10.1016\/j.numecd.2008.07.004_bib17","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2008.07.004_bib18","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","article-title":"Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes","volume":"54","author":"Gault","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm1196-1254","article-title":"Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene","volume":"2","author":"Scrocchi","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2008.07.004_bib20","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.96.26.14843","article-title":"Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice","volume":"96","author":"Miyawaki","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2008.07.004_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI200420518","article-title":"Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors","volume":"113","author":"Preitner","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2008.07.004_bib22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diabetes.53.5.1326","article-title":"Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors","volume":"53","author":"Hansotia","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib23","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2008.07.004_bib24","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jc.87.8.3555","article-title":"Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study","volume":"87","author":"Pontiroli","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2008.07.004_bib25","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2337\/diacare.28.11.2703","article-title":"Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case\u2013controlled study","volume":"28","author":"Pontiroli","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2008.07.004_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jama.299.3.316","article-title":"Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial","volume":"299","author":"Dixon","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2008.07.004_bib27","doi-asserted-by":"crossref","first-page":"S582","DOI":"10.1093\/ajcn\/55.2.582s","article-title":"Surgical treatment of obesity and its effect on diabetes: 10-year follow-up","volume":"55","author":"Pories","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2008.07.004_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000658-199805000-00004","article-title":"A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?","volume":"227","author":"Hickey","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.sla.0000133117.12646.48","article-title":"The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism","volume":"240","author":"Rubino","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000102989.54824.fc","article-title":"Effect of duodenal\u2013jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease","volume":"239","author":"Rubino","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/bjs.1800660906","article-title":"Bilio-pancreatic bypass for obesity. II. Initial experience in man","volume":"66","author":"Scopinaro","year":"1979","journal-title":"Br J Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s001250050721","article-title":"Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids","volume":"40","author":"Mingrone","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2008.07.004_bib33","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00125-006-0337-x","article-title":"Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function","volume":"49","author":"Mari","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2008.07.004_bib34","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/db06-0068","article-title":"Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery","volume":"55","author":"Guidone","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diabetes.48.6.1258","article-title":"Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency","volume":"48","author":"Mingrone","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2337\/diabetes.52.5.1098","article-title":"Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery","volume":"52","author":"Polyzogopoulou","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjsurg.2006.11.015","article-title":"The effects of duodenal\u2013jejunal exclusion on hormonal regulation of glucose metabolism in Goto\u2013Kakizaki rats","volume":"194","author":"Pacheco","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jss.2007.02.022","article-title":"Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study","volume":"141","author":"Whitson","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.numecd.2008.07.004_bib39","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes","volume":"30","author":"Laferr\u00e8re","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2008.07.004_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/diabetes.51.1.144","article-title":"Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion","volume":"51","author":"Greco","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2337\/diabetes.53.4.939","article-title":"Restoration of adiponectin pulsatility in severely obese subjects after weight loss","volume":"53","author":"Calvani","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib42","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.2337\/diabetes.53.suppl_3.S26","article-title":"Beta-cell function in obesity: effects of weight loss","volume":"53","author":"Ferrannini","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib43","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.2337\/diabetes.54.8.2382","article-title":"Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss","volume":"54","author":"Camastra","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2008.07.004_bib44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1096\/fj.04-3453fje","article-title":"Leptin pulsatility in formerly obese women","volume":"19","author":"Mingrone","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.numecd.2008.07.004_bib45","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ajcn\/81.6.1292","article-title":"Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery","volume":"81","author":"Valera-Mora","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2008.07.004_bib46","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2337\/dc06-1353","article-title":"Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?","volume":"30","author":"Manco","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2008.07.004_bib47","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ijo.0803630","article-title":"Molecular mechanisms of diabetes reversibility after bariatric surgery","volume":"31","author":"Rosa","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/j.numecd.2008.07.004_bib48","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/dc06-1845","article-title":"Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery","volume":"30","author":"Camastra","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2008.07.004_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.amjmed.2004.08.017","article-title":"Differential effect of weight loss on insulin resistance in surgically treated obese patients","volume":"118","author":"Muscelli","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2008.07.004_bib50","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s00125-007-0782-1","article-title":"Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure","volume":"50","author":"Gastaldi","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2008.07.004_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa043690","article-title":"Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery","volume":"353","author":"Service","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2008.07.004_bib52","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.gassur.2006.04.008","article-title":"Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia","volume":"10","author":"Clancy","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11695-007-9096-0","article-title":"Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery","volume":"17","author":"Alvarez","year":"2007","journal-title":"Obes Surg"},{"key":"10.1016\/j.numecd.2008.07.004_bib54","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1210\/jc.2007-0918","article-title":"Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal","volume":"92","author":"Goldfine","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475308001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475308001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T02:29:23Z","timestamp":1557800963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475308001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0939475308001580"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2008.07.004","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}